Photodynamic Therapy in Treatment of Verrucae

N/AUnknownNCT04620785

Alexandria University80 enrolled

Overview

To assess the efficacy (clinically and dermoscopically) and safety of photodynamic therapy using intralesional injection of 4% methylene blue solution as a photosensitizer with IPL versus IPL only in treatment of warts.

This study will be conducted on: Eighty patients suffering of verruca (male and female) divided randomly into three groups: group A, B\&C : Group A: 30 patients will undergo photodynamic therapy using intralesional 4%methylene blue solution and IPL. Group B: 30 patients will undergo IPL only. Group C (control group):20 patients will undergo intralesional saline.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Verruca Vulgaris

Interventions

methylene blue / IPLOTHER

therapeutic

IPLOTHER

therapeutic

salineOTHER

placebo

Eligibility

Sex: ALLMin age: 16 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1. Age:Above 16 years old. 2. Sex:Both males and female patients. 3. Clinically and dermoscopically documented verruca. 4. No verruca treatment in the last 2 weeks. Exclusion Criteria: 1. History of photosensitivity disorder. 2. Pregnant and lactating females. 3. Diseases with risk of koebnerization e.g. Psoriasis and Lichen planus. 4. Anogenital warts. 5. Warts on head and neck.

Locations (1)

Alexandria University Faculty of Medicine

Alexandria, Egypt

RECRUITING

Outcomes

Primary Outcomes

disappearance of verruca

clinical and dermoscopic cure

Time frame: 10 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.